Just looking at the Big Pic after the dust settles and IMO;
1.Novartis pulling the plug is not such a big deal.
2.MSB achieved what the doubters yapped about for years; it actually obtained FDA approval. It's got the runs on the board now even if it goes without Novartis.
IMO this is massively oversold by the herd running on today's news; the herd will run back once it absorbs the above.
My 'proof' is that so man of us stuck by MSB, including 'deep pocket', Alex Waislitz, BEFORE it had FDA approval. Crazy to bail out after approval just cos of this tiny bump on the road. This will bounce back nicely.
Ann: Update on Novartis Agreement, page-240
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.045(3.33%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.42 | $1.33 | $3.802M | 2.753M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23940 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 22571 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |